Filter By Category
Archives
ACLERASTIDE
Generic Name: ACLERASTIDE
ABSTRACT -
Aclerastide is an investigational peptide-based compound being studied for its potential role in tissue repair and wound healing. It acts on specific cellular receptors to promote regenerative processes. Research is ongoing to evaluate its safety and efficacy profile across various clinical indications.
DOSAGE -
Aclerastide is an investigational drug. Dosage varies by clinical study protocol and indication. Typically administered via topical or parenteral routes in research settings. No established dosage for routine clinical use.
SIDE EFFECTS –
Reported or potential side effects may include:
- Local application site reactions
- Mild redness or irritation
- Headache
- Nausea
- Fatigue
- Mild gastrointestinal symptoms
ALLRGIC REACTIONS–
(These symptoms may indicate an allergic reaction to the drug.)
- Skin rash
- Itching
- Swelling of face, lips, tongue, or throat
- Difficulty breathing
- Severe dizziness
- Rapid heartbeat
DRUG INTERACTIONS–
- Growth factors
- Wound healing agents
- Anti-inflammatory medications
- Corticosteroids
- Other regenerative therapies
PREAUTIONS–
- Safety in pregnancy and breastfeeding not established.
- Inform physician of prior allergic reactions.
- Monitoring required during administration.
- Caution in patients with severe systemic illness.
- Participate only under clinical trial protocols.
WARNINGS –
- Not approved for general medical use.
- Long-term safety under evaluation.
- Administer only under qualified medical supervision.
- Keep out of reach of children.
- Report adverse events promptly.



. Developed by